Sarcoidosis-associated pulmonary hypertension due to pulmonary arteries stenosis – a case report

Abstract Background Sarcoidosis-associated pulmonary hypertension (SAPH) is listed in Group 5 of the clinical classification of pulmonary hypertension, due to its complex and multifactorial pathophysiology. The most common cause of SAPH development is advanced lung fibrosis with the associated destr...

Full description

Bibliographic Details
Published in:BMC Pulmonary Medicine
Main Authors: Malgorzata Sobiecka, Izabela Siemion-Szczesniak, Barbara Burakowska, Marcin Kurzyna, Malgorzata Dybowska, Witold Tomkowski, Monika Szturmowicz
Format: Article
Language:English
Published: BMC 2024-07-01
Subjects:
Sarcoidosis
Pulmonary hypertension
SAPH
Treatment
Corticosteroids
Balloon pulmonary angioplasty
Online Access:https://doi.org/10.1186/s12890-024-03152-0

Internet

https://doi.org/10.1186/s12890-024-03152-0

Similar Items